• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.76% Nasdaq Up0.71%

    Acceleron Pharma, Inc. (XLRN)

    -NasdaqGM
    30.63 Down 1.01(3.19%) 11:25AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 4,420   3,738   3,509   4,078  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,420   3,738   3,509   4,078  
    Operating Expenses
    Research Development14,779  14,579  11,876  12,677  
    Selling General and Administrative4,700  3,714  3,023  3,712  
    Non Recurring -   -   -  5,000  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (15,059) (14,555) (11,390) (17,311)
    Income from Continuing Operations
    Total Other Income/Expenses Net485  (3,062)3,418  761  
    Earnings Before Interest And Taxes(14,574)(17,617)(7,972)(16,550)
    Interest Expense -   -   -   -  
    Income Before Tax(14,574)(17,617)(7,972)(16,550)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(14,574)(17,617)(7,972)(16,550)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (14,574) (17,617) (7,972) (16,550)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (14,574) (17,617) (7,972) (16,550)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.